Bio-UV Group SA

Bio-UV Group SA

0.89
EUR
+0.05
(+5.46%)
21.68MMarket Cap
Apr 07Next Earn
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.23
2.23
1.61
2.54
3.74
3.3
5.04
4.24
3.95
2.64
- -
Basic EPS, GAAP
0.16
-0.02
0.01
-0.06
0.07
0.07
0.24
0.01
- -
0.06
- -
Free Cash Flow per Basic Share
-0.09
0.44
-0.25
-0.32
-0.36
0.06
0.05
0.42
0.5
0.22
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
0.05
0.06
- -
- -
- -
Book Value per Share
1.17
1.16
2.14
2.15
3.07
3.02
3.19
3.17
3.26
2.98
3.26
Tangible Book Value per Share
-0.14
-0.64
0.83
-0.11
1.22
-0.71
-0.72
-0.59
-0.41
0.34
-0.41
Basic Weighted Avg Shares
8
5
8
8
9
10
10
10
10
14
10
Sales/Revenue/Turnover
10
10
12
20
32
33
51
43
40
36
- -
Operating Margin (%)
-3.51
3.99
0.16
-1.54
4.4
3.06
8.09
5.36
5.39
4.33
- -
Depreciation Expense
1
1
1
2
2
3
3
3
3
3
- -
Net Income, GAAP
1
- -
- -
- -
1
1
2
- -
- -
1
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
17.29
- -
66.02
7.25
- -
Profit Margin (%)
13.27
-0.9
0.37
-2.24
1.81
2.06
4.71
0.29
0.08
2.33
- -
Working Capital
2
3
10
9
23
16
19
22
15
6
15
LT Debt
6
8
7
13
14
31
29
28
24
6
24
Total Equity
6
6
17
16
30
31
32
32
33
41
33
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
4.64
- -
1.04
2.22
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
4.21
- -
0.44
2.51
- -
Return on Common Equity (%)
- -
-1.51
0.41
-2.74
2.53
2.27
7.67
0.39
0.1
2.28
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
ST Debt
10
6
6
LT Borrowings
15
17
16
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
25
23
22

Working Capital

EUR

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
Total Current Assets
28
26
24
Cash, Cash Equivalents & STI
3
3
4
Accounts Receivable, Net
5
5
3
Inventories
15
13
11
Total Current Liabilities
6
15
9
Payables & Accruals
- -
- -
- -
ST Debt
10
6
6
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
6.42%
24%
Free Cash Flow
- -
127.96%
-39.72%
Net Income, GAAP
- -
533.17%
2,566.8%
Sales/Revenue/Turnover
- -
4.77%
-9.27%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
43
2024
- -
- -
40
2025
- -
- -
36

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.01
2024
- -
- -
- -
2025
- -
- -
0.06

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.06
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
Laurent-Emmanuel Migeon
Full Time Employees
143
Sector
Producer manufacturing
Industry
Industrial machinery
Address
850 avenue Louis Medard Lunel OC France 34400
IPO Date
Jul 10, 2018
Website
bio-uv.com
Business
BIO-UV Group S.A. specializes in designing, manufacturing, and marketing advanced water treatment and surface disinfection systems utilizing ultraviolet (UV-C) technology, ozone, salt electrolysis, and advanced oxidation processes (AOP). Its core product portfolio includes water and surface disinfection equipment for residential and collective swimming pools and spas, municipal and domestic water treatment, industrial water treatment for process water disinfection in food and beverage industries, wastewater treatment and recycling solutions, and ballast water management systems compliant with International Maritime Organization (IMO) and United States Coast Guard (USCG) standards. The group also offers a complete ballast water treatment system branded BIO-SEA, combining mechanical filtration and UV disinfection, designed and manufactured in France. BIO-UV serves a global customer base across Europe, North America, and other international markets from its headquarters in Lunel and Muret, France, with significant operations in the UK and Glasgow. Founded in 2000, BIO-UV Group operates through three main divisions: Product Sales, Solution Sales, and Services & Aftermarket. The company targets diverse sectors, including aquaculture, public utilities, industrial water treatment, and the maritime industry. BIO-UV has positioned itself as a European leader in water treatment solutions, with over 35 years of expertise and a turnover reaching nearly €40 million in 2024, more than half of which derives from international sales. Recent major changes at BIO-UV Group include strategic leadership appointments aimed at accelerating growth and transformation, notably the promotion of Jean Philippe Picard de Muller to Deputy General Manager, emphasizing the expansion of after-sales and service activities seen as the most profitable segment with significant growth potential. The company has formalized a key multinational partnership with US-based Innovasea to expand its presence and product adaptation in the North American aquaculture market. This alliance supports BIO-UV’s intensified focus on sustainable aquaculture solutions, leveraging its advanced UV and ozone water treatment technologies acquired through the 2019 purchase of Triogen Holdings Limited. Additionally, BIO-UV has undertaken an equity share buyback program authorized in mid-2025 to bolster shareholder value. These developments reflect BIO-UV Group's commitment to growth through innovation, market expansion, and strengthening its operational and commercial leadership globally.